Abstract
It is increasingly recognized that there is a connection between diet, intestinal microbiota, intestinal barrier function and the low-grade inflammation that characterizes the progression from obesity to metabolic disturbances, making dietary strategies to modulate the intestinal environment relevant. In this context, the ability of some Gram-positive anaerobic bacteria to produce the short-chain fatty acid butyrate is interesting. A lower abundance of butyrate-producing bacteria has been associated with metabolic risk in humans, and recent studies suggest that butyrate might have an anti-inflammatory potential that can alleviate obesity-related metabolic complications, possibly due to its ability to enhance the intestinal barrier function. Here, we review and discuss the potential of butyrate as an anti-inflammatory mediator in metabolic diseases, and the potential for dietary interventions increasing the intestinal availability of butyrate.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Obesity Reviews |
| Vol/bind | 14 |
| Udgave nummer | 12 |
| Sider (fra-til) | 950-959 |
| Antal sider | 10 |
| ISSN | 1467-7881 |
| DOI | |
| Status | Udgivet - dec. 2013 |
FN’s Verdensmål
Dette resultat bidrager til følgende verdensmål
